{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:44:11Z","timestamp":1791927851791,"version":"4.3.4"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12602-024-10427-9","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T22:08:29Z","timestamp":1734041309000},"page":"1797-1819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gut Dysbiosis and Probiotic Therapy in Chronic Kidney Disease: A Comprehensive Review"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3411-2884","authenticated-orcid":false,"given":"Fernanda Priscila Barbosa","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4847-0699","authenticated-orcid":false,"given":"Micaelle Oliveira","family":"de Luna Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0375-8389","authenticated-orcid":false,"given":"Daniella","family":"de Oliveira Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1525-7741","authenticated-orcid":false,"given":"Marry Aneyts","family":"de Santana Cirilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-3809","authenticated-orcid":false,"given":"Jos\u00e9 Luiz","family":"de Brito Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"10427_CR1","doi-asserted-by":"publisher","first-page":"790783","DOI":"10.3389\/fmed.2021.790783","volume":"8","author":"E Wehedy","year":"2021","unstructured":"Wehedy E, Shatat IF, Al KS (2021) The human microbiome in chronic kidney disease: a double-edged sword. Front Med (Lausanne) 8:790783","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10427_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","volume":"16","author":"M Ruiz-Ortega","year":"2020","unstructured":"Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR (2020) Targeting the progression of chronic kidney disease. Nat Rev Nephrol 16(5):269\u2013288","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10427_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12325-021-01927-z","volume":"39","author":"M Evans","year":"2022","unstructured":"Evans M, Lewis RD, Morgan AR, Whyte MB, Hanif W, Bain SC et al (2022) A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives. Adv Ther 39(1):33\u201343","journal-title":"Adv Ther"},{"key":"10427_CR4","doi-asserted-by":"publisher","first-page":"1101068","DOI":"10.3389\/fphar.2023.1101068","volume":"14","author":"S Alshahrani","year":"2023","unstructured":"Alshahrani S (2023) Renin-angiotensin-aldosterone pathway modulators in chronic kidney disease: a comparative review. Front Pharmacol 14:1101068","journal-title":"Front Pharmacol"},{"issue":"3","key":"10427_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/jmf.2017.3990","volume":"21","author":"JS Park","year":"2018","unstructured":"Park JS, Choi JW, Jhun J, Kwon JY, Lee BI, Yang CW et al (2018) Lactobacillus acidophilus improves intestinal inflammation in an acute colitis mouse model by regulation of Th17 and Treg cell balance and fibrosis development. J Med Food 21(3):215\u2013224","journal-title":"J Med Food"},{"key":"10427_CR6","doi-asserted-by":"crossref","unstructured":"de Araujo Henriques Ferreira G, Magnani M, Cabral L, Brandao LR, Noronha MF, de Campos Cruz J et al (2022) potentially probiotic limosilactobacillus fermentum fruit-derived strains alleviate cardiometabolic disorders and gut microbiota impairment in male rats fed a high-fat diet. Probiotics Antimicrob Proteins 14(2):349-59","DOI":"10.1007\/s12602-021-09889-y"},{"issue":"2","key":"10427_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.jrn.2022.07.008","volume":"33","author":"M Mitrovic","year":"2023","unstructured":"Mitrovic M, Stankovic-Popovic V, Tolinacki M, Golic N, Sokovic Bajic S, Veljovic K et al (2023) The impact of synbiotic treatment on the levels of gut-derived uremic toxins, inflammation, and gut microbiome of chronic kidney disease patients-a randomized trial. J Ren Nutr 33(2):278\u2013288","journal-title":"J Ren Nutr"},{"issue":"17","key":"10427_CR8","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.3390\/ijms21176402","volume":"21","author":"B Allam-Ndoul","year":"2020","unstructured":"Allam-Ndoul B, Castonguay-Paradis S, Veilleux A (2020) Gut microbiota and intestinal trans-epithelial permeability. Int J Mol Sci 21(17):6402","journal-title":"Int J Mol Sci"},{"key":"10427_CR9","doi-asserted-by":"publisher","first-page":"625913","DOI":"10.3389\/fcimb.2021.625913","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhou J, Wang L (2021) Role and mechanism of gut microbiota in human disease. Front Cell Infect Microbiol 11:625913","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10427_CR10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/jcm9020336","volume":"9","author":"CN Hsu","year":"2020","unstructured":"Hsu CN, Chang-Chien GP, Lin S, Hou CY, Lu PC, Tain YL (2020) Association of trimethylamine, trimethylamine n-oxide, and dimethylamine with cardiovascular risk in children with chronic kidney disease. J Clin Med 9(2):336","journal-title":"J Clin Med"},{"issue":"24","key":"10427_CR11","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1007\/s00018-019-03155-9","volume":"76","author":"YL Feng","year":"2019","unstructured":"Feng YL, Cao G, Chen DQ, Vaziri ND, Chen L, Zhang J et al (2019) Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cell Mol Life Sci 76(24):4961\u20134978","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10427_CR12","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","volume":"69","author":"X Wang","year":"2020","unstructured":"Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J et al (2020) Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 69(12):2131\u20132142","journal-title":"Gut"},{"issue":"2","key":"10427_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/nu15020360","volume":"15","author":"N Li","year":"2023","unstructured":"Li N, Wang Y, Wei P, Min Y, Yu M, Zhou G et al (2023) Causal effects of specific gut microbiota on chronic kidney diseases and renal function-a two-sample mendelian randomization study. Nutrients 15(2):360","journal-title":"Nutrients"},{"issue":"12","key":"10427_CR14","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/ckj\/sfac154","volume":"15","author":"BM Beker","year":"2022","unstructured":"Beker BM, Colombo I, Gonzalez-Torres H, Musso CG (2022) Decreasing microbiota-derived uremic toxins to improve CKD outcomes. Clin Kidney J 15(12):2214\u20132219","journal-title":"Clin Kidney J"},{"issue":"4","key":"10427_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/toxins13040252","volume":"13","author":"J Rysz","year":"2021","unstructured":"Rysz J, Franczyk B, Lawinski J, Olszewski R, Cialkowska-Rysz A, Gluba-Brzozka A (2021) The impact of CKD on uremic toxins and gut microbiota. Toxins (Basel) 13(4):252","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10427_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3904\/kjim.2020.411","volume":"35","author":"SM Kim","year":"2020","unstructured":"Kim SM, Song IH (2020) The clinical impact of gut microbiota in chronic kidney disease. Korean J Intern Med 35(6):1305\u20131316","journal-title":"Korean J Intern Med"},{"key":"10427_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.biopha.2017.06.066","volume":"93","author":"F Mahmoodpoor","year":"2017","unstructured":"Mahmoodpoor F, Rahbar Saadat Y, Barzegari A, Ardalan M, ZununiVahed S (2017) The impact of gut microbiota on kidney function and pathogenesis. Biomed Pharmacother 93:412\u2013419","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10427_CR18","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B et al (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506\u201314","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"19","key":"10427_CR19","doi-asserted-by":"publisher","first-page":"e1800298","DOI":"10.1002\/mnfr.201800298","volume":"62","author":"I Robles-Vera","year":"2018","unstructured":"Robles-Vera I, Toral M, de la Visitacion N, Sanchez M, Romero M, Olivares M et al (2018) The probiotic Lactobacillus fermentum prevents dysbiosis and vascular oxidative stress in rats with hypertension induced by chronic nitric oxide blockade. Mol Nutr Food Res 62(19):e1800298","journal-title":"Mol Nutr Food Res"},{"key":"10427_CR20","doi-asserted-by":"publisher","first-page":"1033063","DOI":"10.3389\/fimmu.2022.1033063","volume":"13","author":"C He","year":"2022","unstructured":"He C, Xie Y, Zhu Y, Zhuang K, Huo L, Yu Y et al (2022) Probiotics modulate gastrogut microbiota after Helicobacter pylori eradication: a multicenter randomized double-blind placebo-controlled trial. Front Immunol 13:1033063","journal-title":"Front Immunol"},{"issue":"1","key":"10427_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/nu12010222","volume":"12","author":"IN Sergeev","year":"2020","unstructured":"Sergeev IN, Aljutaily T, Walton G, Huarte E (2020) Effects of synbiotic supplement on human gut microbiota, body composition and weight loss in obesity. Nutrients 12(1):222","journal-title":"Nutrients"},{"issue":"1","key":"10427_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12882-022-02890-9","volume":"23","author":"A Lydia","year":"2022","unstructured":"Lydia A, Indra TA, Rizka A, Abdullah M (2022) The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: a randomized controlled trial. BMC Nephrol 23(1):259","journal-title":"BMC Nephrol"},{"key":"10427_CR23","doi-asserted-by":"publisher","first-page":"1107869","DOI":"10.3389\/fnut.2023.1107869","volume":"10","author":"F Hevilla","year":"2023","unstructured":"Hevilla F, Padial M, Blanca M, Barril G, Jimenez-Salcedo T, Ramirez-Ortiz M et al (2023) Effect on nutritional status and biomarkers of inflammation and oxidation of an oral nutritional supplement (with or without probiotics) in malnourished hemodialysis patients. A multicenter randomized clinical trial \u201cRenacare Trial.\u201d Front Nutr 10:1107869","journal-title":"Front Nutr"},{"issue":"2","key":"10427_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1053\/j.jrn.2020.07.002","volume":"31","author":"PS Lim","year":"2021","unstructured":"Lim PS, Wang HF, Lee MC, Chiu LS, Wu MY, Chang WC et al (2021) The efficacy of lactobacillus-containing probiotic supplementation in hemodialysis patients: a randomized, double-blind, placebo-controlled trial. J Ren Nutr 31(2):189\u2013198","journal-title":"J Ren Nutr"},{"issue":"10302","key":"10427_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V (2021) Chronic kidney disease. Lancet 398(10302):786\u2013802","journal-title":"Lancet"},{"issue":"9","key":"10427_CR26","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.47391\/JPMA.01-114","volume":"71","author":"S Imtiaz","year":"2021","unstructured":"Imtiaz S, Alam A (2021) Strategies for preventing end stage kidney disease: the impact of kidney stone disease on chronic kidney disease in Pakistan. J Pak Med Assoc 71(9):2244\u20132246","journal-title":"J Pak Med Assoc"},{"issue":"5","key":"10427_CR27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s40620-019-00635-w","volume":"32","author":"H Kiriyama","year":"2019","unstructured":"Kiriyama H, Kaneko H, Itoh H, Yoshida Y, Nakanishi K, Mizuno Y et al (2019) Correction to: Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study. J Nephrol 32(5):843\u2013846","journal-title":"J Nephrol"},{"issue":"Suppl 02","key":"10427_CR28","doi-asserted-by":"publisher","first-page":"E190010 SUPL 2","DOI":"10.1590\/1980-549720190010.supl.2","volume":"22","author":"DC Malta","year":"2019","unstructured":"Malta DC, Machado IE, Pereira CA, Figueiredo AW, Aguiar LK, Almeida WDS et al (2019) Evaluation of renal function in the Brazilian adult population, according to laboratory criteria from the National Health Survey. Rev Bras Epidemiol 22(Suppl 02):E190010 SUPL 2","journal-title":"Rev Bras Epidemiol"},{"key":"10427_CR29","doi-asserted-by":"publisher","first-page":"204062232311772","DOI":"10.1177\/20406223231177291","volume":"14","author":"HM Tsao","year":"2023","unstructured":"Tsao HM, Lai TS, Chou YH, Lin SL, Chen YM (2023) Predialysis trajectories of estimated GFR and concurrent trends of chronic kidney disease-relevant biomarkers. Ther Adv Chronic Dis 14:20406223231177292","journal-title":"Ther Adv Chronic Dis"},{"issue":"4S","key":"10427_CR30","first-page":"S117","volume":"105","author":"Kidney disease: improving global outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney disease: improving global outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4S):S117\u2013S314","journal-title":"Kidney Int"},{"issue":"10075","key":"10427_CR31","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic kidney disease. Lancet 389(10075):1238\u20131252","journal-title":"Lancet"},{"issue":"3","key":"10427_CR32","first-page":"251","volume":"37","author":"U Kumar","year":"2019","unstructured":"Kumar U, Wettersten N, Garimella PS (2019) Cardiorenal syndrome: pathophysiology. Cardiol Clin 37(3):251\u2013265","journal-title":"Cardiol Clin"},{"issue":"11","key":"10427_CR33","first-page":"e296","volume":"40","author":"JC Grim","year":"2020","unstructured":"Grim JC, Aguado BA, Vogt BJ, Batan D, Andrichik CL, Schroeder ME et al (2020) Secreted factors from proinflammatory macrophages promote an osteoblast-like phenotype in valvular interstitial cells. ArteriosclerThrombVasc Biol 40(11):e296\u2013e308","journal-title":"ArteriosclerThrombVasc Biol"},{"key":"10427_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fendo.2018.00256","volume":"9","author":"CML Barbosa","year":"2018","unstructured":"Barbosa CML, Ferrao FM, Graceli JB (2018) Organotin compounds toxicity: focus on kidney. Front Endocrinol (Lausanne) 9:256","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10427_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.pop.2020.08.001","volume":"47","author":"C Charles","year":"2020","unstructured":"Charles C, Ferris AH (2020) Chronic kidney disease. Prim Care 47(4):585\u2013595","journal-title":"Prim Care"},{"issue":"10","key":"10427_CR36","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/toxins14100648","volume":"14","author":"S Bhargava","year":"2022","unstructured":"Bhargava S, Merckelbach E, Noels H, Vohra A, Jankowski J (2022) Homeostasis in the gut microbiota in chronic kidney disease. Toxins (Basel) 14(10):648","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10427_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/toxins13020142","volume":"13","author":"YJ Lim","year":"2021","unstructured":"Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL (2021) Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets. Toxins (Basel) 13(2):142","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10427_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00018-018-2943-4","volume":"76","author":"A Adak","year":"2019","unstructured":"Adak A, Khan MR (2019) An insight into gut microbiota and its functionalities. Cell Mol Life Sci 76(3):473\u2013493","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10427_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/cells12050793","volume":"12","author":"J Wang","year":"2023","unstructured":"Wang J, Zhu N, Su X, Gao Y, Yang R (2023) Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells 12(5):793","journal-title":"Cells"},{"issue":"9","key":"10427_CR40","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/nu15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F et al (2023) Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients 15(9):2211","journal-title":"Nutrients"},{"issue":"12","key":"10427_CR41","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s11255-019-02291-2","volume":"51","author":"C Plata","year":"2019","unstructured":"Plata C, Cruz C, Cervantes LG, Ramirez V (2019) The gut microbiota and its relationship with chronic kidney disease. Int Urol Nephrol 51(12):2209\u20132226","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10427_CR42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/nu13030886","volume":"13","author":"SP Wiertsema","year":"2021","unstructured":"Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ (2021) The interplay between the gut microbiome and the immune system in the context of infectious diseases throughout life and the role of nutrition in optimizing treatment strategies. Nutrients 13(3):886","journal-title":"Nutrients"},{"issue":"8","key":"10427_CR43","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.3390\/nu12082216","volume":"12","author":"M Mazidi","year":"2020","unstructured":"Mazidi M, Shekoohi N, Covic A, Mikhailidis DP, Banach M (2020) Adverse impact of Desulfovibrio spp. and Beneficial Role of Anaerostipes spp. on renal function: insights from a Mendelian randomization analysis. Nutrients 12(8):2216","journal-title":"Nutrients"},{"issue":"6","key":"10427_CR44","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1681\/ASN.2021060843","volume":"33","author":"HT Linh","year":"2022","unstructured":"Linh HT, Iwata Y, Senda Y, Sakai-Takemori Y, Nakade Y, Oshima M et al (2022) Intestinal bacterial translocation contributes to diabetic kidney disease. J Am Soc Nephrol 33(6):1105\u20131119","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10427_CR45","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/toxins12090590","volume":"12","author":"AL Graboski","year":"2020","unstructured":"Graboski AL, Redinbo MR (2020) Gut-derived protein-bound uremic toxins. Toxins (Basel) 12(9):590","journal-title":"Toxins (Basel)"},{"issue":"11","key":"10427_CR46","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/ndt\/gfy171","volume":"34","author":"CI Ramos","year":"2019","unstructured":"Ramos CI, Armani RG, Canziani MEF, Dalboni MA, Dolenga CJR, Nakao LS, Campbell KL, Cuppari L (2019) Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial. Nephrol Dial Transplant 34(11):1876\u20131884","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10427_CR47","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1093\/ndt\/gfr624","volume":"27","author":"ND Vaziri","year":"2012","unstructured":"Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS (2012) Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant 27(7):2686\u20132693","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10427_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12967-018-1756-4","volume":"17","author":"YY Chen","year":"2019","unstructured":"Chen YY, Chen DQ, Chen L, Liu JR, Vaziri ND, Guo Y et al (2019) Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med 17(1):5","journal-title":"J Transl Med"},{"issue":"4","key":"10427_CR49","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.apsb.2022.12.010","volume":"13","author":"L Pan","year":"2023","unstructured":"Pan L, Yu H, Fu J, Hu J, Xu H, Zhang Z et al (2023) Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota. Acta Pharm Sin B 13(4):1537\u20131553","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"10427_CR50","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3390\/microorganisms8121862","volume":"8","author":"R Ikee","year":"2020","unstructured":"Ikee R, Sasaki N, Yasuda T, Fukazawa S (2020) Chronic kidney disease, gut dysbiosis, and constipation: a burdensome triplet. Microorganisms 8(12):1862","journal-title":"Microorganisms"},{"issue":"8","key":"10427_CR51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1440-1797.2012.01647.x","volume":"17","author":"F Wang","year":"2012","unstructured":"Wang F, Jiang H, Shi K, Ren Y, Zhang P, Cheng S (2012) Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology (Carlton) 17(8):733\u2013738","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"10427_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41581-019-0111-1","volume":"15","author":"SK Nigam","year":"2019","unstructured":"Nigam SK, Bush KT (2019) Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling. Nat Rev Nephrol 15(5):301\u2013316","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10427_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40620-018-0516-0","volume":"32","author":"C Cosola","year":"2019","unstructured":"Cosola C, Rocchetti MT, Sabatino A, Fiaccadori E, Di Iorio BR, Gesualdo L (2019) Microbiota issue in CKD: how promising are gut-targeted approaches? J Nephrol 32(1):27\u201337","journal-title":"J Nephrol"},{"issue":"6","key":"10427_CR54","doi-asserted-by":"publisher","first-page":"e001852","DOI":"10.1161\/JAHA.115.001852","volume":"4","author":"H Han","year":"2015","unstructured":"Han H, Zhu J, Zhu Z, Ni J, Du R et al (2015) p-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes. J Am Heart Assoc 4(6):e001852","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10427_CR55","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2012.448","volume":"83","author":"H Watanabe","year":"2013","unstructured":"Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q et al (2013) p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 83(4):582\u2013592","journal-title":"Kidney Int"},{"issue":"1","key":"10427_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/ndt\/gft367","volume":"29","author":"J Poveda","year":"2014","unstructured":"Poveda J, Sanchez-Ni\u00f1o MD, Glorieux G, Sanz AB, Egido J et al (2014) p-Cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells. Nephrol Dial Transplant 29(1):56\u201364","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10427_CR57","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.tiv.2015.07.020","volume":"29","author":"HA Mutsaers","year":"2015","unstructured":"Mutsaers HA, Caetano-Pinto P, Seegers AE, Dankers AC, van den Broek PH et al (2015) Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology. Toxicol In Vitro 29(7):1868\u20131877","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"10427_CR58","doi-asserted-by":"publisher","first-page":"F380","DOI":"10.1152\/ajprenal.00175.2010","volume":"299","author":"F Palm","year":"2010","unstructured":"Palm F, Nangaku M, Fasching A, Tanaka T, Nordquist L et al (2010) Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress. Am J Physiol Renal Physiol 299(2):F380\u2013F386","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10427_CR59","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/ki.2012.434","volume":"83","author":"Y Gorin","year":"2013","unstructured":"Gorin Y (2013) Nox4 as a potential therapeutic target for treatment of uremic toxicity associated to chronic kidney disease. Kidney Int 83(4):541\u2013543","journal-title":"Kidney Int"},{"issue":"11","key":"10427_CR60","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/toxins12110684","volume":"12","author":"TH Cheng","year":"2020","unstructured":"Cheng TH, Ma MC, Liao MT, Zheng CM, Lu KC et al (2020) Indoxyl sulfate, a tubular toxin, contributes to the development of chronic kidney disease. Toxins (Basel) 12(11):684","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10427_CR61","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA et al (2015) Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 116(3):448\u2013455","journal-title":"Circ Res"},{"issue":"2","key":"10427_CR62","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.bbrc.2017.09.108","volume":"493","author":"G Sun","year":"2017","unstructured":"Sun G, Yin Z, Liu N, Bian X, Yu R et al (2017) Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity. Biochem Biophys Res Commun 493(2):964\u2013970","journal-title":"Biochem Biophys Res Commun"},{"key":"10427_CR63","doi-asserted-by":"publisher","first-page":"929262","DOI":"10.3389\/fphar.2022.929262","volume":"13","author":"Y Zixin","year":"2022","unstructured":"Zixin Y, Lulu C, Xiangchang Z, Qing F, Binjie Z et al (2022) TMAO as a potential biomarker and therapeutic target for chronic kidney disease: a review. Front Pharmacol 13:929262","journal-title":"Front Pharmacol"},{"key":"10427_CR64","doi-asserted-by":"publisher","first-page":"682482","DOI":"10.3389\/fphys.2021.682482","volume":"12","author":"Q Fang","year":"2021","unstructured":"Fang Q, Zheng B, Liu N, Liu J, Liu W et al (2021) Trimethylamine N-oxide exacerbates renal inflammation and fibrosis in rats with diabetic kidney disease. Front Physiol 12:682482","journal-title":"Front Physiol"},{"issue":"3","key":"10427_CR65","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/ATVBAHA.119.313414","volume":"40","author":"X Zhang","year":"2020","unstructured":"Zhang X, Li Y, Yang P, Liu X, Lu L et al (2020) Trimethylamine-N-oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-\u03baB (nuclear factor \u03baB) signals. Arterioscler Thromb Vasc Biol 40(3):751\u2013765","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10427_CR66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-1536-6-18","volume":"6","author":"L Walkin","year":"2013","unstructured":"Walkin L, Herrick SE, Summers A, Brenchley PE, Hoff CM, Korstanje R et al (2013) The role of mouse strain differences in the susceptibility to fibrosis: a systematic review. Fibrogenesis Tissue Repair 6(1):18","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"3","key":"10427_CR67","doi-asserted-by":"publisher","first-page":"e34026","DOI":"10.1371\/journal.pone.0034026","volume":"7","author":"CY Sun","year":"2012","unstructured":"Sun CY, Chang SC, Wu MS (2012) Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition. PLoS ONE 7(3):e34026","journal-title":"PLoS ONE"},{"issue":"13\u201314","key":"10427_CR68","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.lfs.2012.01.013","volume":"90","author":"H Shimizu","year":"2012","unstructured":"Shimizu H, Bolati D, Higashiyama Y, Nishijima F, Shimizu K, Niwa T (2012) Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-kappaB, p53, ERK, and JNK in proximal tubular cells. Life Sci 90(13\u201314):525\u2013530","journal-title":"Life Sci"},{"issue":"12","key":"10427_CR69","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.3390\/ijms22126196","volume":"22","author":"A Pieniazek","year":"2021","unstructured":"Pieniazek A, Bernasinska-Slomczewska J, Gwozdzinski L (2021) Uremic toxins and their relation with oxidative stress induced in patients with CKD. Int J Mol Sci 22(12):6196","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10427_CR70","doi-asserted-by":"publisher","first-page":"F487","DOI":"10.1152\/ajprenal.00092.2018","volume":"315","author":"LD Chaves","year":"2018","unstructured":"Chaves LD, McSkimming DI, Bryniarski MA, Honan AM, Abyad S, Thomas SA et al (2018) Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis. Am J Physiol Renal Physiol 315(3):F487\u2013F502","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10427_CR71","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ et al (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83(2):308\u2013315","journal-title":"Kidney Int"},{"issue":"1","key":"10427_CR72","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1038\/s41598-017-02989-2","volume":"7","author":"S Jiang","year":"2017","unstructured":"Jiang S, Xie S, Lv D, Wang P, He H, Zhang T et al (2017) Alteration of the gut microbiota in Chinese population with chronic kidney disease. Sci Rep 7(1):2870","journal-title":"Sci Rep"},{"issue":"1","key":"10427_CR73","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/toxins14010008","volume":"14","author":"JH Chen","year":"2021","unstructured":"Chen JH, Chiang CK (2021) Uremic toxins and protein-bound therapeutics in AKI and CKD: up-to-date evidence. Toxins (Basel) 14(1):8","journal-title":"Toxins (Basel)"},{"issue":"10","key":"10427_CR74","first-page":"CD013631","volume":"10","author":"TE Cooper","year":"2023","unstructured":"Cooper TE, Khalid R, Chan S, Craig JC, Hawley CM, Howell M, Johnson DW, Jaure A, Teixeira-Pinto A, Wong G (2023) Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cochrane Database Syst Rev 10(10):CD013631","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10427_CR75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ncp.10662","volume":"37","author":"M Ribeiro","year":"2022","unstructured":"Ribeiro M, Fonseca L, Anjos JS, Capo-Chichi JCC, Borges NA, Burrowes J, Mafra D (2022) Oral iron supplementation in patients with chronic kidney disease: can it be harmful to the gut microbiota? Nutr Clin Pract 37(1):81\u201393","journal-title":"Nutr Clin Pract"},{"issue":"9","key":"10427_CR76","doi-asserted-by":"publisher","first-page":"226","DOI":"10.31083\/j.fbl2809226","volume":"28","author":"L Zhu","year":"2023","unstructured":"Zhu L, Niu J, Tang XC, Shan LH, Xiao L, Wang YQ et al (2023) The effects of probiotic Lactobacillus rhamnosus GG on fecal flora and serum markers of renal injury in mice with chronic kidney disease. Front Biosci (Landmark Ed) 28(9):226","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"10427_CR77","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12906-023-04068-8","volume":"23","author":"A Gholami","year":"2023","unstructured":"Gholami A, Montazeri-Najafabady N, Ashoori Y, Kazemi K, Heidari R, Omidifar N et al (2023) The ameliorating effect of Limosilactobacillus fermentum and its supernatant postbiotic on cisplatin-induced chronic kidney disease in an animal model. BMC Complement Med Ther 23(1):243","journal-title":"BMC Complement Med Ther"},{"issue":"3","key":"10427_CR78","doi-asserted-by":"publisher","first-page":"e0281745","DOI":"10.1371\/journal.pone.0281745","volume":"18","author":"T Inatomi","year":"2023","unstructured":"Inatomi T, Honma M (2023) Ameliorating effect of probiotics in a rat model of chronic kidney disease. PLoS ONE 18(3):e0281745","journal-title":"PLoS ONE"},{"issue":"26","key":"10427_CR79","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1021\/acs.jafc.1c01547","volume":"69","author":"H Huang","year":"2021","unstructured":"Huang H, Li K, Lee Y, Chen M (2021) Preventive effects of Lactobacillus mixture against chronic kidney disease progression through enhancement of beneficial bacteria and downregulation of gut-derived uremic toxins. J Agric Food Chem 69(26):7353\u20137366","journal-title":"J Agric Food Chem"},{"issue":"24","key":"10427_CR80","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1111\/jcmm.17626","volume":"26","author":"T Pei","year":"2022","unstructured":"Pei T, Zhu D, Yang S, Hu R, Wang F, Zhang J et al (2022) Bacteroides plebeius improves muscle wasting in chronic kidney disease by modulating the gut-renal muscle axis. J Cell Mol Med 26(24):6066\u20136078","journal-title":"J Cell Mol Med"},{"issue":"9","key":"10427_CR81","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1161\/CIRCRESAHA.122.320184","volume":"131","author":"HB Li","year":"2022","unstructured":"Li HB, Xu ML, Xu XD, Tang YY, Jiang HL, Li L et al (2022) Faecalibacterium prausnitzii attenuates CKD via butyrate-renal GPR43 axis. Circ Res 131(9):e120\u2013e134","journal-title":"Circ Res"},{"issue":"22","key":"10427_CR82","doi-asserted-by":"publisher","first-page":"e2101105","DOI":"10.1002\/mnfr.202101105","volume":"66","author":"H Kim","year":"2022","unstructured":"Kim H, Nam BY, Park J, Song S, Kim WK, Lee K et al (2022) Lactobacillus acidophilus KBL409 reduces kidney fibrosis via immune modulatory effects in mice with chronic kidney disease. Mol Nutr Food Res 66(22):e2101105","journal-title":"Mol Nutr Food Res"},{"issue":"8","key":"10427_CR83","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/ndt\/gfac032","volume":"37","author":"S Tungsanga","year":"2022","unstructured":"Tungsanga S, Katavetin P, Panpetch W, Udompornpitak K, Saisorn W, Praditpornsilpa K et al (2022) Lactobacillus rhamnosus L34 attenuates chronic kidney disease progression in a 5\/6 nephrectomy mouse model through the excretion of anti-inflammatory molecules. Nephrol Dial Transplant 37(8):1429\u20131442","journal-title":"Nephrol Dial Transplant"},{"key":"10427_CR84","doi-asserted-by":"publisher","first-page":"112701","DOI":"10.1016\/j.biopha.2022.112701","volume":"147","author":"YS Tsai","year":"2022","unstructured":"Tsai YS, Chen YP, Lin SW, Chen YL, Chen CC, Huang GJ (2022) Lactobacillus rhamnosus GKLC1 ameliorates cisplatin-induced chronic nephrotoxicity by inhibiting cell inflammation and apoptosis. Biomed Pharmacother 147:112701","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10427_CR85","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.cmet.2021.06.014","volume":"33","author":"H Zhu","year":"2021","unstructured":"Zhu H, Cao C, Wu Z, Zhang H, Sun Z, Wang M et al (2021) The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease. Cell Metab 33(10):1926\u201342","journal-title":"Cell Metab"},{"issue":"4","key":"10427_CR86","first-page":"1130","volume":"45","author":"TH Lee","year":"2020","unstructured":"Lee TH, Park D, Kim YJ, Lee I, Kim S, Oh CT et al (2020) Lactobacillus salivarius BP121 prevents cisplatin-induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p-cresol sulfate via alleviating dysbiosis. Int J Mol Med 45(4):1130\u20131140","journal-title":"Int J Mol Med"},{"key":"10427_CR87","doi-asserted-by":"publisher","first-page":"661794","DOI":"10.3389\/fnut.2021.661794","volume":"8","author":"IK Wang","year":"2021","unstructured":"Wang IK, Yen TH, Hsieh PS, Ho HH, Kuo YW, Huang YY et al (2021) Effect of a probiotic combination in an experimental mouse model and clinical patients with chronic kidney disease: a pilot study. Front Nutr 8:661794","journal-title":"Front Nutr"},{"key":"10427_CR88","doi-asserted-by":"publisher","first-page":"120856","DOI":"10.1016\/j.lfs.2022.120856","volume":"306","author":"SJ Moon","year":"2022","unstructured":"Moon SJ, Hwang J, Kang WK, Ahn JP, Kim HJ (2022) Administration of the probiotic Lactiplantibacillus paraplantarum is effective in controlling hyperphosphatemia in 5\/6 nephrectomy rat model. Life Sci 306:120856","journal-title":"Life Sci"},{"issue":"5","key":"10427_CR89","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.3390\/ijms23052511","volume":"23","author":"S Tungsanga","year":"2022","unstructured":"Tungsanga S, Panpetch W, Bhunyakarnjanarat T, Udompornpitak K, Katavetin P, Chancharoenthana W et al (2022) Uremia-induced gut barrier defect in 5\/6 nephrectomized mice is worsened by candida administration through a synergy of uremic toxin, lipopolysaccharide, and (1\u27943)-beta-D-glucan, but is attenuated by Lacticaseibacillus rhamnosus L34. Int J Mol Sci. 23(5):2511","journal-title":"Int J Mol Sci."},{"key":"10427_CR90","doi-asserted-by":"publisher","unstructured":"Dong Y, Gai Z, Han M, Xu J, Zou K (2024) Reduction in serum concentrations of uremic toxins driven by Bifidobacterium longum subsp. longum BL21 is associated with gut microbiota changes in a rat model of chronic kidney disease. Probiotics Antimicrob Proteins. https:\/\/doi.org\/10.1007\/s12602-024-10293-5","DOI":"10.1007\/s12602-024-10293-5"},{"issue":"8","key":"10427_CR91","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00394-024-03461-4","volume":"63","author":"J Park","year":"2024","unstructured":"Park J, Nam KH, Nam BY, Kim G, Kim H, Lee KU et al (2024) Correction: Lactobacillus acidophilus KBL409 protects against kidney injury via improving mitochondrial function in mice with chronic kidney disease. Eur J Nutr 63(8):3289","journal-title":"Eur J Nutr"},{"issue":"2","key":"10427_CR92","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/biom10020347","volume":"10","author":"M Fontecha-Barriuso","year":"2020","unstructured":"Fontecha-Barriuso M, Martin-Sanchez D, Martinez-Moreno JM, Monsalve M, Ramos AM, Sanchez-Nino MD et al (2020) The role of PGC-1alpha and mitochondrial biogenesis in kidney diseases. Biomolecules 10(2):347","journal-title":"Biomolecules"},{"issue":"2","key":"10427_CR93","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1681\/ASN.2014121208","volume":"27","author":"H Peng","year":"2016","unstructured":"Peng H, Cao J, Yu R, Danesh F, Wang Y, Mitch WE et al (2016) CKD stimulates muscle protein loss via Rho-associated protein kinase 1 activation. J Am Soc Nephrol 27(2):509\u2013519","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10427_CR94","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1007\/s00394-020-02207-2","volume":"59","author":"S Liu","year":"2020","unstructured":"Liu S, Liu H, Chen L, Liang SS, Shi K, Meng W et al (2020) Effect of probiotics on the gut microbiota of hemodialysis patients: a randomized trial. Eur J Nutr 59(8):3755\u20133766","journal-title":"Eur J Nutr"},{"key":"10427_CR95","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.clnesp.2018.08.010","volume":"28","author":"F Eidi","year":"2018","unstructured":"Eidi F, Poor-Reza Gholi F, Ostadrahimi A, Dalili N, Samadian F, Barzegari A (2018) Effect of Lactobacillus rhamnosus on serum uremic toxins (phenol and P-Cresol) in hemodialysis patients: a double blind randomized clinical trial. Clin Nutr ESPEN 28:158\u2013164","journal-title":"Clin Nutr ESPEN"},{"issue":"8","key":"10427_CR96","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1185\/03007990903069249","volume":"25","author":"N Ranganathan","year":"2009","unstructured":"Ranganathan N, Friedman EA, Tam P, Rao V, Ranganathan P, Dheer R (2009) Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin 25(8):1919\u20131930","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10427_CR97","doi-asserted-by":"publisher","first-page":"89","DOI":"10.23876\/j.krcp.21.014","volume":"41","author":"E Choi","year":"2022","unstructured":"Choi E, Yang J, Ji GE, Park MS, Seong Y, Oh SW et al (2022) The effect of probiotic supplementation on systemic inflammation in dialysis patients. Kidney Res Clin Pract 41(1):89\u2013101","journal-title":"Kidney Res Clin Pract"},{"issue":"5","key":"10427_CR98","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s00394-018-1785-z","volume":"58","author":"M Simeoni","year":"2019","unstructured":"Simeoni M, Citraro ML, Cerantonio A, Deodato F, Provenzano M, Cianfrone P et al (2019) An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD). Eur J Nutr 58(5):2145\u20132156","journal-title":"Eur J Nutr"},{"key":"10427_CR99","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.foodres.2018.08.024","volume":"116","author":"RCSO Lopes","year":"2019","unstructured":"Lopes RCSO, Theodoro JMV, da Silva BP, Queiroz VAV, de Castro Moreira ME et al (2019) Synbiotic meal decreases uremic toxins in hemodialysis individuals: a placebo-controlled trial. Food Res Int 116:241\u2013248","journal-title":"Food Res Int"},{"issue":"4","key":"10427_CR100","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s12602-018-9499-3","volume":"11","author":"A Soleimani","year":"2019","unstructured":"Soleimani A, Motamedzadeh A, Zarrati Mojarrad M, Bahmani F, Amirani E et al (2019) The effects of synbiotic supplementation on metabolic status in diabetic patients undergoing hemodialysis: a randomized, double-blinded, placebo-controlled trial. Probiotics Antimicrob Proteins 11(4):1248\u20131256","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"4","key":"10427_CR101","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s12602-018-9477-9","volume":"11","author":"N Haghighat","year":"2019","unstructured":"Haghighat N, Mohammadshahi M, Shayanpour S, Haghighizadeh MH (2019) Effect of synbiotic and probiotic supplementation on serum levels of endothelial cell adhesion molecules in hemodialysis patients: a randomized control study. Probiotics Antimicrob Proteins 11(4):1210\u20131218","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10427_CR102","doi-asserted-by":"crossref","unstructured":"Sasso CV, Lhamyani S, Hevilla F, Padial M, Blanca M, et al. Modulation of miR-29a and miR-29b expression and their target genes related to inflammation and renal fibrosis by an oral nutritional supplement with probiotics in malnourished hemodialysis patients. Int J Mol Sci. 2024; 17;25(2):1132.","DOI":"10.3390\/ijms25021132"},{"key":"10427_CR103","doi-asserted-by":"crossref","unstructured":"L\u00facio HG, Lopes RCSO, Gomes MJC, da Silva A, Grancieri M et al (2024) A symbiotic meal containing extruded sorghum and probiotic (Bifidobacterium longum) ameliorated intestinal health markers in individuals with chronic kidney disease: a secondary analysis of a subsample from a previous randomized and controlled clinical trial. Nutrients 16(12):1852","DOI":"10.3390\/nu16121852"},{"issue":"12","key":"10427_CR104","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.3390\/nu13124481","volume":"13","author":"C McFarlane","year":"2021","unstructured":"McFarlane C, Krishnasamy R, Stanton T, Savill E, Snelson M et al (2021) Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II) a feasibility randomized controlled trial. Nutrients 13(12):4481","journal-title":"Nutrients"},{"issue":"5","key":"10427_CR105","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/toxins13050334","volume":"13","author":"C Cosola","year":"2021","unstructured":"Cosola C, Rocchetti MT, di Bari I, Acquaviva PM, Maranzano V et al (2021) An innovative synbiotic formulation decreases free serum indoxyl sulfate, small intestine permeability and ameliorates gastrointestinal symptoms in a randomized pilot trial in stage IIIb-IV CKD patients. Toxins (Basel) 13(5):334","journal-title":"Toxins (Basel)"},{"issue":"8","key":"10427_CR106","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/nu14081637","volume":"14","author":"A De Mauri","year":"2022","unstructured":"De Mauri A, Carrera D, Bagnati M, Rolla R, Vidali M et al (2022) Probiotics-supplemented low-protein diet for microbiota modulation in patients with advanced chronic kidney disease (ProLowCKD): results from a placebo-controlled randomized trial. Nutrients 14(8):1637","journal-title":"Nutrients"},{"issue":"4","key":"10427_CR107","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.119.14294","volume":"75","author":"S Kim","year":"2020","unstructured":"Kim S, Rigatto K, Gazzana MB, Knorst MM, Richards EM, Pepine CJ et al (2020) Altered gut microbiome profile in patients with pulmonary arterial hypertension. Hypertension 75(4):1063\u20131071","journal-title":"Hypertension"},{"issue":"4","key":"10427_CR108","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/CS20210778","volume":"136","author":"L Liang","year":"2022","unstructured":"Liang L, Liu L, Zhou W, Yang C, Mai G, Li H et al (2022) Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage\/WNT\/ERK signaling pathway. Clin Sci (Lond) 136(4):291\u2013307","journal-title":"Clin Sci (Lond)"},{"issue":"6418","key":"10427_CR109","doi-asserted-by":"publisher","first-page":"eaat9076","DOI":"10.1126\/science.aat9076","volume":"362","author":"Y Litvak","year":"2018","unstructured":"Litvak Y, Byndloss MX, B\u00e4umler AJ (2018) Colonocyte metabolism shapes the gut microbiota. Science 362(6418):eaat9076","journal-title":"Science"},{"issue":"3","key":"10427_CR110","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00467-003-1353-4","volume":"19","author":"K Musia\u0142","year":"2004","unstructured":"Musia\u0142 K, Zwoli\u0144ska D, Polak-Jonkisz D, Berny U, Szprynger K, Szczepa\u0144ska M (2004) Soluble adhesion molecules in children and young adults on chronic hemodialysis. Pediatr Nephrol 19(3):332\u2013336","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10427_CR111","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00467-004-1691-x","volume":"20","author":"K Musia\u0142","year":"2005","unstructured":"Musia\u0142 K, Zwoli\u0144ska D, Polak-Jonkisz D, Berny U, Szprynger K, Szczepa\u0144ska M (2005) Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure. Pediatr Nephrol 20(1):52\u201355","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10427_CR112","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0029665120006916","volume":"80","author":"C Martin-Gallausiaux","year":"2021","unstructured":"Martin-Gallausiaux C, Marinelli L, Blotti\u00e8re HM, Larraufie P, Lapaque N (2021) SCFA: mechanisms and functional importance in the gut. Proc Nutr Soc 80(1):37\u201349","journal-title":"Proc Nutr Soc"},{"issue":"7","key":"10427_CR113","first-page":"925","volume":"15","author":"A O'Callaghan","year":"2016","unstructured":"O\u2019Callaghan A, van Sinderen D (2016) Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol 15(7):925","journal-title":"Front Microbiol"},{"issue":"1","key":"10427_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1875796","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Mao B, Gu J, Wu J, Cui S et al (2021) Blautia-a new functional genus with potential probiotic properties? Gut Microbes 13(1):1\u201321","journal-title":"Gut Microbes"},{"issue":"3","key":"10427_CR115","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.semnephrol.2010.03.003","volume":"30","author":"JS Duffield","year":"2010","unstructured":"Duffield JS (2010) Macrophages and immunologic inflammation of the kidney. Semin Nephrol 30(3):234\u2013254","journal-title":"Semin Nephrol"},{"issue":"5","key":"10427_CR116","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.kint.2017.11.036","volume":"93","author":"MG Vervloet","year":"2018","unstructured":"Vervloet MG, van Ballegooijen AJ (2018) Prevention and treatment of hyperphosphatemia in chronic kidney disease. Kidney Int 93(5):1060\u20131072","journal-title":"Kidney Int"},{"issue":"3","key":"10427_CR117","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/ndt\/gfq818","volume":"26","author":"BK Meijers","year":"2011","unstructured":"Meijers BK, Evenepoel P (2011) The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant 26(3):759\u2013761","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10427_CR118","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12967-018-1471-1","volume":"16","author":"IW Achkar","year":"2018","unstructured":"Achkar IW, Abdulrahman N, Al-Sulaiti H, Joseph JM, Uddin S, Mraiche F (2018) Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway. J Transl Med 16(1):96","journal-title":"J Transl Med"},{"key":"10427_CR119","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","volume":"101","author":"L Chen","year":"2018","unstructured":"Chen L, Yang T, Lu DW, Zhao H, Feng YL, Chen H et al (2018) Central role of dysregulation of TGF-beta\/Smad in CKD progression and potential targets of its treatment. Biomed Pharmacother 101:670\u2013681","journal-title":"Biomed Pharmacother"},{"key":"10427_CR120","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/978-981-13-8871-2_16","volume":"1165","author":"TT Ma","year":"2019","unstructured":"Ma TT, Meng XM (2019) TGF-beta\/Smad and Renal Fibrosis. Adv Exp Med Biol 1165:347\u2013364","journal-title":"Adv Exp Med Biol"},{"key":"10427_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107279","volume":"91","author":"Y Li","year":"2021","unstructured":"Li Y, Guo F, Huang R, Ma L, Fu P (2021) Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFbeta\/SMAD3 and JAK2\/STAT3 signaling. Int Immunopharmacol 91:107279","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10427_CR122","doi-asserted-by":"publisher","first-page":"F1151","DOI":"10.1152\/ajprenal.00034.2019","volume":"316","author":"J Pace","year":"2019","unstructured":"Pace J, Paladugu P, Das B, He JC, Mallipattu SK (2019) Targeting STAT3 signaling in kidney disease. Am J Physiol Renal Physiol 316(6):F1151\u2013F1161","journal-title":"Am J Physiol Renal Physiol"},{"issue":"13","key":"10427_CR123","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1039\/D1FO00589H","volume":"12","author":"X Long","year":"2021","unstructured":"Long X, Sun F, Wang Z, Liu T, Gong J, Kan X et al (2021) Lactobacillus fermentum CQPC08 protects rats from lead-induced oxidative damage by regulating the Keap1\/Nrf2\/ARE pathway. Food Funct 12(13):6029\u20136044","journal-title":"Food Funct"},{"issue":"16","key":"10427_CR124","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1021\/acs.jafc.0c00717","volume":"68","author":"T Wu","year":"2020","unstructured":"Wu T, Sun M, Liu R, Sui W, Zhang J, Yin J et al (2020) Bifidobacterium longum subsp. longum remodeled roseburia and phosphatidylserine levels and ameliorated intestinal disorders and liver metabolic abnormalities induced by high-fat diet. J Agric Food Chem 68(16):4632\u201340","journal-title":"J Agric Food Chem"},{"key":"10427_CR125","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.2147\/DDDT.S150825","volume":"11","author":"L Li","year":"2017","unstructured":"Li L, Ma L, Fu P (2017) Gut microbiota-derived short-chain fatty acids and kidney diseases. Drug Des Devel Ther 11:3531\u20133542","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"10427_CR126","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/ajh\/hpaa103","volume":"33","author":"I Robles-Vera","year":"2020","unstructured":"Robles-Vera I, Toral M, Duarte J (2020) Microbiota and hypertension: role of the sympathetic nervous system and the immune system. Am J Hypertens 33(10):890\u2013901","journal-title":"Am J Hypertens"},{"issue":"4","key":"10427_CR127","doi-asserted-by":"publisher","first-page":"e0175336","DOI":"10.1371\/journal.pone.0175336","volume":"12","author":"F Awad","year":"2017","unstructured":"Awad F, Assrawi E, Jumeau C, Georgin-Lavialle S, Cobret L, Duquesnoy P et al (2017) Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation. PLoS ONE 12(4):e0175336","journal-title":"PLoS ONE"},{"issue":"12","key":"10427_CR128","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, Nunez G (2016) Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci 41(12):1012\u20131021","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"10427_CR129","doi-asserted-by":"publisher","first-page":"F367","DOI":"10.1152\/ajprenal.00571.2013","volume":"306","author":"R Che","year":"2014","unstructured":"Che R, Yuan Y, Huang S, Zhang A (2014) Mitochondrial dysfunction in the pathophysiology of renal diseases. Am J Physiol Renal Physiol 306(4):F367\u2013F378","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10427_CR130","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","volume":"92","author":"DL Galvan","year":"2017","unstructured":"Galvan DL, Green NH, Danesh FR (2017) The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney Int 92(5):1051\u20131057","journal-title":"Kidney Int"},{"issue":"1","key":"10427_CR131","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F et al (2015) Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 21(1):37\u201346","journal-title":"Nat Med"},{"issue":"4","key":"10427_CR132","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1681\/ASN.2017070802","volume":"29","author":"KW Chung","year":"2018","unstructured":"Chung KW, Lee EK, Lee MK, Oh GT, Yu BP, Chung HY (2018) Impairment of PPARalpha and the fatty acid oxidation pathway aggravates renal fibrosis during aging. J Am Soc Nephrol 29(4):1223\u20131237","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10427_CR133","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00424-010-0919-9","volume":"461","author":"VC Foletta","year":"2011","unstructured":"Foletta VC, White LJ, Larsen AE, Leger B, Russell AP (2011) The role and regulation of MAFbx\/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch 461(3):325\u2013335","journal-title":"Pflugers Arch"},{"issue":"2","key":"10427_CR134","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1210\/endrev\/bnab030","volume":"43","author":"BD Rodgers","year":"2022","unstructured":"Rodgers BD, Ward CW (2022) Myostatin\/activin receptor ligands in muscle and the development status of attenuating drugs. Endocr Rev 43(2):329\u2013365","journal-title":"Endocr Rev"},{"issue":"3","key":"10427_CR135","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.jrn.2018.08.008","volume":"29","author":"C McFarlane","year":"2019","unstructured":"McFarlane C, Ramos CI, Johnson DW, Campbell KL (2019) Prebiotic, probiotic, and synbiotic supplementation in chronic kidney disease: a systematic review and meta-analysis. J Ren Nutr 29(3):209\u2013220","journal-title":"J Ren Nutr"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10427-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-024-10427-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10427-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:05:25Z","timestamp":1756901125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-024-10427-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":135,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10427"],"URL":"https:\/\/doi.org\/10.1007\/s12602-024-10427-9","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"6 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript is a review. Ethics in publishing is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}